Availability of new dosages for hydroxychloroquine—a first-line therapy for systemic lupus—may be best for patients, shows a survey conducted by the Lupus Foundation of America.
While significant advances have been made in the treatment of systemic lupus erythematosus (SLE), the highly variable manifestations of the disease make treatment difficult.
Reporting in the Oct. 14 issue of The American Journal of Medicine, Kristopher Ahn, M.D., and Rukma Govindu, M.D., describe a case of an otherwise healthy 36-year-old African American woman who presents to the emergency department for treatment of a long-lasting skin rash. As her ED visit unfolds, it turns into a complicated, challenging, difficult to diagnose case. Learn more in this featured case study.
In this week's Rheumatology Network news roundup, we highlight advances in rheumatology research featured in recent issues of the New England Journal of Medicince, the journal Rheumatology and others. Among the most interesting findings was a study that highlights a link between antibiotic use and rheumatoid arthritis. Learn more in this slidesshow.
The Arthritis Foundation has just released the first CBD guidance for adults with arthritis. CBD, or cannabidiol, a plant-based compound, has become popular among people with arthritis seeking to ease chronic joint pain. Learn more in this slideshow.
The American Society for Bone and Mineral Research has developed a set of treatment recommendations for the prevention of secondary fracture in patients 65 years and older who have had a hip or vertebral fracture. There are 13 recommendations. In this slideshow, we highlight the recommendations beginning with improved doctor-patient communication.
Rheumatic conditions are associated with dermatological manifestations some of which are commonly known and others not so well known. In this slideshow, we highlight four conditions that should be on your radar.
The clinical burden of fracture on Medicare fee-for-service beneficiaries is significant, with patients continuing to experience additional fractures at high rates. The survival after a subsequent fracture is approximately 180 days, shows a report issued in August by the National Osteoporosis Foundation
In this slideshow, we highlight 12 recommendations for assessing MRI lesions on the sacroiliac joints of patients with spondyloarthritis. The recommendations were made by the Assessment of Spondyloarthritis International Society (ASAS) MRI working group and published in the British journal Annals of the Rheumatic Diseases earlier this year.
In this installment of our psoriatic arthritis quiz, we focus on features associated with the five types of psoriatic arthritis. Can you identify all types of psoriatic arthritis and address how best to treat each condition?